Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $14.4100 (-6.67%) ($14.3400 - $14.4100) on Wed. Jan. 12, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.92% (three month average) | RSI | 40 | Latest Price | $14.4100(-6.67%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.5% a day on average for past five trading days. | Weekly Trend | ATRA declines -4.6% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) IBB(48%) ARKG(47%) ARKK(47%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -1.96% in a week (0% probabilities). VIXM(-42%) VXX(-31%) UNG(-18%) USO(-13%) TLT(-10%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.96% (StdDev 3.92%) | Hourly BBV | -2.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $6.4(-55.59%) | Resistance Level | $16.03 | 5 Day Moving Average | $15.49(-6.97%) | 10 Day Moving Average | $15.77(-8.62%) | 20 Day Moving Average | $16.03(-10.11%) | To recent high | -27.6% | To recent low | 0% | Market Cap | $1.071b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |